aluates Reports

$ 0.0

Automative

Global Human Microbiome Market Research Report 2025

Published Date: August 2025

Report Code: QYRE-Auto-12A183

Global Human Microbiome Market Size Status and Forecast 2021 2027

BUY CHAPTERS

Global Human Microbiome Market Research Report 2025

Code: QYRE-Auto-12A183

Report

August 2025

Pages:92

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Vedanta

Seres Therapeutics

Second Genome

Rebiotix

ActoGeniX

Enterome BioScience

AvidBiotics

4D Pharma Research Ltd

Enterologics

Metabogen

Metabiomics

Ritter Pharmaceuticals

Osel

Symberix

Miomics

Symbiotix Biotherapies

MicroBiome Therapeutics LLC

Human Microbiome Market Size

The global market for Human Microbiome was valued at US$ 568 million in the year 2024 and is projected to reach a revised size of US$ 3351 million by 2031, growing at a CAGR of 30.5% during the forecast period.

Human Microbiome Market

The Human Microbiome refers to the collective microorganisms and their genetic material residing in various parts of the human body, such as the gut, skin, mouth, respiratory tract, and reproductive system. These microbes form a symbiotic relationship with the human host, playing critical roles in immune modulation, nutrient absorption, metabolic regulation, and disease prevention. With the advancement of high-throughput sequencing, synthetic biology, and artificial intelligence, the commercialization of the microbiome is shifting from basic research toward precision medicine, immunotherapy, probiotics, functional foods, and personalized nutrition. The global human microbiome industry is now entering an accelerated application phase, becoming a model for cross-border integration across healthcare, biotechnology, and nutrition sectors, and attracting major pharmaceutical and biotech companies, as well as emerging startups.

The human microbiome sector has gained momentum due to rising demand for precision medicine, chronic disease management, and alternatives to antibiotics. Increasing evidence from Phase III clinical trials supports the role of gut microbiota in conditions such as cancer, neurological disorders, and autoimmune diseases, accelerating product development in therapeutics, diagnostics, and nutritional interventions. The U.S. and EU have included microbiome initiatives in their national-level precision medicine strategies, and investor interest continues to surge. The global market for microbiome therapeutics is projected to surpass $10 billion by 2030.

Despite the promising outlook, the industry faces significant hurdles. These include individual microbiome variability leading to inconsistent treatment efficacy, lack of standardized clinical validation pathways, and regulatory uncertainty. Technological challenges around scalable manufacturing, storage, activity control, and genomic safety further complicate commercialization. Additionally, public acceptance, ethical concerns, and low physician familiarity with microbiome-based therapies present barriers to market expansion.

Downstream, pharmaceutical, nutritional, and diagnostic companies are accelerating commercialization of microbiome-related products. There is growing demand for gut microbiome therapeutics, fecal microbiota transplantation (FMT), probiotics, and next-generation probiotics (NGPs), particularly in cancer support therapy, autism management, and inflammatory bowel disease. Rising consumer awareness of microbiome balance is also fueling demand in functional food and personalized nutrition, turning the sector into a hotbed for venture capital and strategic investment.

This report aims to provide a comprehensive presentation of the global market for Human Microbiome, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Microbiome.

The Human Microbiome market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Human Microbiome market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Human Microbiome companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Human Microbiome Market Report

Report Metric	Details
Report Name	Human Microbiome Market
Accounted market size in year	US$ 568 million
Forecasted market size in 2031	US$ 3351 million
CAGR	30.5%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Gastrointestinal Tract Human Micobiome Urogenital Tract Human Micobiome Others
Segment by Application	Treatment Diagnosis
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Vedanta, Seres Therapeutics, Second Genome, Rebiotix, ActoGeniX, Enterome BioScience, AvidBiotics, 4D Pharma Research Ltd, Enterologics, Metabogen, Metabiomics, Ritter Pharmaceuticals, Osel, Symberix, Miomics, Symbiotix Biotherapies, MicroBiome Therapeutics LLC
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Human Microbiome company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Human Microbiome Market growing?

Ans: The Human Microbiome Market witnessing a CAGR of 30.5% during the forecast period 2025-2031.

What is the Human Microbiome Market size in 2031?

Ans: The Human Microbiome Market size in 2031 will be US$ 3351 million.

Who are the main players in the Human Microbiome Market report?

Ans: The main players in the Human Microbiome Market are Vedanta, Seres Therapeutics, Second Genome, Rebiotix, ActoGeniX, Enterome BioScience, AvidBiotics, 4D Pharma Research Ltd, Enterologics, Metabogen, Metabiomics, Ritter Pharmaceuticals, Osel, Symberix, Miomics, Symbiotix Biotherapies, MicroBiome Therapeutics LLC

What are the Application segmentation covered in the Human Microbiome Market report?

Ans: The Applications covered in the Human Microbiome Market report are Treatment, Diagnosis

What are the Type segmentation covered in the Human Microbiome Market report?

Ans: The Types covered in the Human Microbiome Market report are Gastrointestinal Tract Human Micobiome, Urogenital Tract Human Micobiome, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Human Microbiome Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Gastrointestinal Tract Human Micobiome

1.2.3 Urogenital Tract Human Micobiome

1.2.4 Others

1.3 Market by Application

1.3.1 Global Human Microbiome Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Treatment

1.3.3 Diagnosis

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Human Microbiome Market Perspective (2020-2031)

2.2 Global Human Microbiome Growth Trends by Region

2.2.1 Global Human Microbiome Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Human Microbiome Historic Market Size by Region (2020-2025)

2.2.3 Human Microbiome Forecasted Market Size by Region (2026-2031)

2.3 Human Microbiome Market Dynamics

2.3.1 Human Microbiome Industry Trends

2.3.2 Human Microbiome Market Drivers

2.3.3 Human Microbiome Market Challenges

2.3.4 Human Microbiome Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Human Microbiome Players by Revenue

3.1.1 Global Top Human Microbiome Players by Revenue (2020-2025)

3.1.2 Global Human Microbiome Revenue Market Share by Players (2020-2025)

3.2 Global Top Human Microbiome Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Human Microbiome Revenue

3.4 Global Human Microbiome Market Concentration Ratio

3.4.1 Global Human Microbiome Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Human Microbiome Revenue in 2024

3.5 Global Key Players of Human Microbiome Head office and Area Served

3.6 Global Key Players of Human Microbiome, Product and Application

3.7 Global Key Players of Human Microbiome, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Human Microbiome Breakdown Data by Type

4.1 Global Human Microbiome Historic Market Size by Type (2020-2025)

4.2 Global Human Microbiome Forecasted Market Size by Type (2026-2031)

5 Human Microbiome Breakdown Data by Application

5.1 Global Human Microbiome Historic Market Size by Application (2020-2025)

5.2 Global Human Microbiome Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Human Microbiome Market Size (2020-2031)

6.2 North America Human Microbiome Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Human Microbiome Market Size by Country (2020-2025)

6.4 North America Human Microbiome Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Human Microbiome Market Size (2020-2031)

7.2 Europe Human Microbiome Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Human Microbiome Market Size by Country (2020-2025)

7.4 Europe Human Microbiome Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8 Asia-Pacific

8.1 Asia-Pacific Human Microbiome Market Size (2020-2031)

8.2 Asia-Pacific Human Microbiome Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Human Microbiome Market Size by Region (2020-2025)

8.4 Asia-Pacific Human Microbiome Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9 Latin America

9.1 Latin America Human Microbiome Market Size (2020-2031)

9.2 Latin America Human Microbiome Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Human Microbiome Market Size by Country (2020-2025)

9.4 Latin America Human Microbiome Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Human Microbiome Market Size (2020-2031)

10.2 Middle East & Africa Human Microbiome Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Human Microbiome Market Size by Country (2020-2025)

10.4 Middle East & Africa Human Microbiome Market Size by Country (2026-2031)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Vedanta

11.1.1 Vedanta Company Details

11.1.2 Vedanta Business Overview

11.1.3 Vedanta Human Microbiome Introduction

11.1.4 Vedanta Revenue in Human Microbiome Business (2020-2025)

11.1.5 Vedanta Recent Development

11.2 Seres Therapeutics

11.2.1 Seres Therapeutics Company Details

11.2.2 Seres Therapeutics Business Overview

11.2.3 Seres Therapeutics Human Microbiome Introduction

11.2.4 Seres Therapeutics Revenue in Human Microbiome Business (2020-2025)

11.2.5 Seres Therapeutics Recent Development

11.3 Second Genome

11.3.1 Second Genome Company Details

11.3.2 Second Genome Business Overview

11.3.3 Second Genome Human Microbiome Introduction

11.3.4 Second Genome Revenue in Human Microbiome Business (2020-2025)

11.3.5 Second Genome Recent Development

11.4 Rebiotix

11.4.1 Rebiotix Company Details

11.4.2 Rebiotix Business Overview

11.4.3 Rebiotix Human Microbiome Introduction

11.4.4 Rebiotix Revenue in Human Microbiome Business (2020-2025)

11.4.5 Rebiotix Recent Development

11.5 ActoGeniX

11.5.1 ActoGeniX Company Details

11.5.2 ActoGeniX Business Overview

11.5.3 ActoGeniX Human Microbiome Introduction

11.5.4 ActoGeniX Revenue in Human Microbiome Business (2020-2025)

11.5.5 ActoGeniX Recent Development

11.6 Enterome BioScience

11.6.1 Enterome BioScience Company Details

11.6.2 Enterome BioScience Business Overview

11.6.3 Enterome BioScience Human Microbiome Introduction

11.6.4 Enterome BioScience Revenue in Human Microbiome Business (2020-2025)

11.6.5 Enterome BioScience Recent Development

11.7 AvidBiotics

11.7.1 AvidBiotics Company Details

11.7.2 AvidBiotics Business Overview

11.7.3 AvidBiotics Human Microbiome Introduction

11.7.4 AvidBiotics Revenue in Human Microbiome Business (2020-2025)

11.7.5 AvidBiotics Recent Development

11.8 4D Pharma Research Ltd

11.8.1 4D Pharma Research Ltd Company Details

11.8.2 4D Pharma Research Ltd Business Overview

11.8.3 4D Pharma Research Ltd Human Microbiome Introduction

11.8.4 4D Pharma Research Ltd Revenue in Human Microbiome Business (2020-2025)

11.8.5 4D Pharma Research Ltd Recent Development

11.9 Enterologics

11.9.1 Enterologics Company Details

11.9.2 Enterologics Business Overview

11.9.3 Enterologics Human Microbiome Introduction

11.9.4 Enterologics Revenue in Human Microbiome Business (2020-2025)

11.9.5 Enterologics Recent Development

11.10 Metabogen

11.10.1 Metabogen Company Details

11.10.2 Metabogen Business Overview

11.10.3 Metabogen Human Microbiome Introduction

11.10.4 Metabogen Revenue in Human Microbiome Business (2020-2025)

11.10.5 Metabogen Recent Development

11.11 Metabiomics

11.11.1 Metabiomics Company Details

11.11.2 Metabiomics Business Overview

11.11.3 Metabiomics Human Microbiome Introduction

11.11.4 Metabiomics Revenue in Human Microbiome Business (2020-2025)

11.11.5 Metabiomics Recent Development

11.12 Ritter Pharmaceuticals

11.12.1 Ritter Pharmaceuticals Company Details

11.12.2 Ritter Pharmaceuticals Business Overview

11.12.3 Ritter Pharmaceuticals Human Microbiome Introduction

11.12.4 Ritter Pharmaceuticals Revenue in Human Microbiome Business (2020-2025)

11.12.5 Ritter Pharmaceuticals Recent Development

11.13 Osel

11.13.1 Osel Company Details

11.13.2 Osel Business Overview

11.13.3 Osel Human Microbiome Introduction

11.13.4 Osel Revenue in Human Microbiome Business (2020-2025)

11.13.5 Osel Recent Development

11.14 Symberix

11.14.1 Symberix Company Details

11.14.2 Symberix Business Overview

11.14.3 Symberix Human Microbiome Introduction

11.14.4 Symberix Revenue in Human Microbiome Business (2020-2025)

11.14.5 Symberix Recent Development

11.15 Miomics

11.15.1 Miomics Company Details

11.15.2 Miomics Business Overview

11.15.3 Miomics Human Microbiome Introduction

11.15.4 Miomics Revenue in Human Microbiome Business (2020-2025)

11.15.5 Miomics Recent Development

11.16 Symbiotix Biotherapies

11.16.1 Symbiotix Biotherapies Company Details

11.16.2 Symbiotix Biotherapies Business Overview

11.16.3 Symbiotix Biotherapies Human Microbiome Introduction

11.16.4 Symbiotix Biotherapies Revenue in Human Microbiome Business (2020-2025)

11.16.5 Symbiotix Biotherapies Recent Development

11.17 MicroBiome Therapeutics LLC

11.17.1 MicroBiome Therapeutics LLC Company Details

11.17.2 MicroBiome Therapeutics LLC Business Overview

11.17.3 MicroBiome Therapeutics LLC Human Microbiome Introduction

11.17.4 MicroBiome Therapeutics LLC Revenue in Human Microbiome Business (2020-2025)

11.17.5 MicroBiome Therapeutics LLC Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Vedanta

Seres Therapeutics

Second Genome

Rebiotix

ActoGeniX

Enterome BioScience

AvidBiotics

4D Pharma Research Ltd

Enterologics

Metabogen

Metabiomics

Ritter Pharmaceuticals

Osel

Symberix

Miomics

Symbiotix Biotherapies

MicroBiome Therapeutics LLC

List of Tables

Table 1. Global Human Microbiome Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Gastrointestinal Tract Human Micobiome

Table 3. Key Players of Urogenital Tract Human Micobiome

Table 4. Key Players of Others

Table 5. Global Human Microbiome Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Human Microbiome Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Human Microbiome Market Size by Region (2020-2025) & (US$ Million)

Table 8. Global Human Microbiome Market Share by Region (2020-2025)

Table 9. Global Human Microbiome Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 10. Global Human Microbiome Market Share by Region (2026-2031)

Table 11. Human Microbiome Market Trends

Table 12. Human Microbiome Market Drivers

Table 13. Human Microbiome Market Challenges

Table 14. Human Microbiome Market Restraints

Table 15. Global Human Microbiome Revenue by Players (2020-2025) & (US$ Million)

Table 16. Global Human Microbiome Market Share by Players (2020-2025)

Table 17. Global Top Human Microbiome Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Microbiome as of 2024)

Table 18. Ranking of Global Top Human Microbiome Companies by Revenue (US$ Million) in 2024

Table 19. Global 5 Largest Players Market Share by Human Microbiome Revenue (CR5 and HHI) & (2020-2025)

Table 20. Global Key Players of Human Microbiome, Headquarters and Area Served

Table 21. Global Key Players of Human Microbiome, Product and Application

Table 22. Global Key Players of Human Microbiome, Date of Enter into This Industry

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Human Microbiome Market Size by Type (2020-2025) & (US$ Million)

Table 25. Global Human Microbiome Revenue Market Share by Type (2020-2025)

Table 26. Global Human Microbiome Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 27. Global Human Microbiome Revenue Market Share by Type (2026-2031)

Table 28. Global Human Microbiome Market Size by Application (2020-2025) & (US$ Million)

Table 29. Global Human Microbiome Revenue Market Share by Application (2020-2025)

Table 30. Global Human Microbiome Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 31. Global Human Microbiome Revenue Market Share by Application (2026-2031)

Table 32. North America Human Microbiome Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 33. North America Human Microbiome Market Size by Country (2020-2025) & (US$ Million)

Table 34. North America Human Microbiome Market Size by Country (2026-2031) & (US$ Million)

Table 35. Europe Human Microbiome Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 36. Europe Human Microbiome Market Size by Country (2020-2025) & (US$ Million)

Table 37. Europe Human Microbiome Market Size by Country (2026-2031) & (US$ Million)

Table 38. Asia-Pacific Human Microbiome Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 39. Asia-Pacific Human Microbiome Market Size by Region (2020-2025) & (US$ Million)

Table 40. Asia-Pacific Human Microbiome Market Size by Region (2026-2031) & (US$ Million)

Table 41. Latin America Human Microbiome Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 42. Latin America Human Microbiome Market Size by Country (2020-2025) & (US$ Million)

Table 43. Latin America Human Microbiome Market Size by Country (2026-2031) & (US$ Million)

Table 44. Middle East & Africa Human Microbiome Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 45. Middle East & Africa Human Microbiome Market Size by Country (2020-2025) & (US$ Million)

Table 46. Middle East & Africa Human Microbiome Market Size by Country (2026-2031) & (US$ Million)

Table 47. Vedanta Company Details

Table 48. Vedanta Business Overview

Table 49. Vedanta Human Microbiome Product

Table 50. Vedanta Revenue in Human Microbiome Business (2020-2025) & (US$ Million)

Table 51. Vedanta Recent Development

Table 52. Seres Therapeutics Company Details

Table 53. Seres Therapeutics Business Overview

Table 54. Seres Therapeutics Human Microbiome Product

Table 55. Seres Therapeutics Revenue in Human Microbiome Business (2020-2025) & (US$ Million)

Table 56. Seres Therapeutics Recent Development

Table 57. Second Genome Company Details

Table 58. Second Genome Business Overview

Table 59. Second Genome Human Microbiome Product

Table 60. Second Genome Revenue in Human Microbiome Business (2020-2025) & (US$ Million)

Table 61. Second Genome Recent Development

Table 62. Rebiotix Company Details

Table 63. Rebiotix Business Overview

Table 64. Rebiotix Human Microbiome Product

Table 65. Rebiotix Revenue in Human Microbiome Business (2020-2025) & (US$ Million)

Table 66. Rebiotix Recent Development

Table 67. ActoGeniX Company Details

Table 68. ActoGeniX Business Overview

Table 69. ActoGeniX Human Microbiome Product

Table 70. ActoGeniX Revenue in Human Microbiome Business (2020-2025) & (US$ Million)

Table 71. ActoGeniX Recent Development

Table 72. Enterome BioScience Company Details

Table 73. Enterome BioScience Business Overview

Table 74. Enterome BioScience Human Microbiome Product

Table 75. Enterome BioScience Revenue in Human Microbiome Business (2020-2025) & (US$ Million)

Table 76. Enterome BioScience Recent Development

Table 77. AvidBiotics Company Details

Table 78. AvidBiotics Business Overview

Table 79. AvidBiotics Human Microbiome Product

Table 80. AvidBiotics Revenue in Human Microbiome Business (2020-2025) & (US$ Million)

Table 81. AvidBiotics Recent Development

Table 82. 4D Pharma Research Ltd Company Details

Table 83. 4D Pharma Research Ltd Business Overview

Table 84. 4D Pharma Research Ltd Human Microbiome Product

Table 85. 4D Pharma Research Ltd Revenue in Human Microbiome Business (2020-2025) & (US$ Million)

Table 86. 4D Pharma Research Ltd Recent Development

Table 87. Enterologics Company Details

Table 88. Enterologics Business Overview

Table 89. Enterologics Human Microbiome Product

Table 90. Enterologics Revenue in Human Microbiome Business (2020-2025) & (US$ Million)

Table 91. Enterologics Recent Development

Table 92. Metabogen Company Details

Table 93. Metabogen Business Overview

Table 94. Metabogen Human Microbiome Product

Table 95. Metabogen Revenue in Human Microbiome Business (2020-2025) & (US$ Million)

Table 96. Metabogen Recent Development

Table 97. Metabiomics Company Details

Table 98. Metabiomics Business Overview

Table 99. Metabiomics Human Microbiome Product

Table 100. Metabiomics Revenue in Human Microbiome Business (2020-2025) & (US$ Million)

Table 101. Metabiomics Recent Development

Table 102. Ritter Pharmaceuticals Company Details

Table 103. Ritter Pharmaceuticals Business Overview

Table 104. Ritter Pharmaceuticals Human Microbiome Product

Table 105. Ritter Pharmaceuticals Revenue in Human Microbiome Business (2020-2025) & (US$ Million)

Table 106. Ritter Pharmaceuticals Recent Development

Table 107. Osel Company Details

Table 108. Osel Business Overview

Table 109. Osel Human Microbiome Product

Table 110. Osel Revenue in Human Microbiome Business (2020-2025) & (US$ Million)

Table 111. Osel Recent Development

Table 112. Symberix Company Details

Table 113. Symberix Business Overview

Table 114. Symberix Human Microbiome Product

Table 115. Symberix Revenue in Human Microbiome Business (2020-2025) & (US$ Million)

Table 116. Symberix Recent Development

Table 117. Miomics Company Details

Table 118. Miomics Business Overview

Table 119. Miomics Human Microbiome Product

Table 120. Miomics Revenue in Human Microbiome Business (2020-2025) & (US$ Million)

Table 121. Miomics Recent Development

Table 122. Symbiotix Biotherapies Company Details

Table 123. Symbiotix Biotherapies Business Overview

Table 124. Symbiotix Biotherapies Human Microbiome Product

Table 125. Symbiotix Biotherapies Revenue in Human Microbiome Business (2020-2025) & (US$ Million)

Table 126. Symbiotix Biotherapies Recent Development

Table 127. MicroBiome Therapeutics LLC Company Details

Table 128. MicroBiome Therapeutics LLC Business Overview

Table 129. MicroBiome Therapeutics LLC Human Microbiome Product

Table 130. MicroBiome Therapeutics LLC Revenue in Human Microbiome Business (2020-2025) & (US$ Million)

Table 131. MicroBiome Therapeutics LLC Recent Development

Table 132. Research Programs/Design for This Report

Table 133. Key Data Information from Secondary Sources

Table 134. Key Data Information from Primary Sources

Table 135. Authors List of This Report

List of Figures

Figure 1. Human Microbiome Picture

Figure 2. Global Human Microbiome Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Human Microbiome Market Share by Type: 2024 VS 2031

Figure 4. Gastrointestinal Tract Human Micobiome Features

Figure 5. Urogenital Tract Human Micobiome Features

Figure 6. Others Features

Figure 7. Global Human Microbiome Market Size by Application (2020-2031) & (US$ Million)

Figure 8. Global Human Microbiome Market Share by Application: 2024 VS 2031

Figure 9. Treatment Case Studies

Figure 10. Diagnosis Case Studies

Figure 11. Human Microbiome Report Years Considered

Figure 12. Global Human Microbiome Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 13. Global Human Microbiome Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 14. Global Human Microbiome Market Share by Region: 2024 VS 2031

Figure 15. Global Human Microbiome Market Share by Players in 2024

Figure 16. Global Human Microbiome Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 17. The Top 10 and 5 Players Market Share by Human Microbiome Revenue in 2024

Figure 18. North America Human Microbiome Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 19. North America Human Microbiome Market Share by Country (2020-2031)

Figure 20. United States Human Microbiome Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. Canada Human Microbiome Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Europe Human Microbiome Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Human Microbiome Market Share by Country (2020-2031)

Figure 24. Germany Human Microbiome Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. France Human Microbiome Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. U.K. Human Microbiome Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Italy Human Microbiome Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Russia Human Microbiome Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Ireland Human Microbiome Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Asia-Pacific Human Microbiome Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Human Microbiome Market Share by Region (2020-2031)

Figure 32. China Human Microbiome Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Japan Human Microbiome Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. South Korea Human Microbiome Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Southeast Asia Human Microbiome Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. India Human Microbiome Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Australia & New Zealand Human Microbiome Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Latin America Human Microbiome Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Human Microbiome Market Share by Country (2020-2031)

Figure 40. Mexico Human Microbiome Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Brazil Human Microbiome Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Middle East & Africa Human Microbiome Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Human Microbiome Market Share by Country (2020-2031)

Figure 44. Israel Human Microbiome Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Saudi Arabia Human Microbiome Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. UAE Human Microbiome Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Vedanta Revenue Growth Rate in Human Microbiome Business (2020-2025)

Figure 48. Seres Therapeutics Revenue Growth Rate in Human Microbiome Business (2020-2025)

Figure 49. Second Genome Revenue Growth Rate in Human Microbiome Business (2020-2025)

Figure 50. Rebiotix Revenue Growth Rate in Human Microbiome Business (2020-2025)

Figure 51. ActoGeniX Revenue Growth Rate in Human Microbiome Business (2020-2025)

Figure 52. Enterome BioScience Revenue Growth Rate in Human Microbiome Business (2020-2025)

Figure 53. AvidBiotics Revenue Growth Rate in Human Microbiome Business (2020-2025)

Figure 54. 4D Pharma Research Ltd Revenue Growth Rate in Human Microbiome Business (2020-2025)

Figure 55. Enterologics Revenue Growth Rate in Human Microbiome Business (2020-2025)

Figure 56. Metabogen Revenue Growth Rate in Human Microbiome Business (2020-2025)

Figure 57. Metabiomics Revenue Growth Rate in Human Microbiome Business (2020-2025)

Figure 58. Ritter Pharmaceuticals Revenue Growth Rate in Human Microbiome Business (2020-2025)

Figure 59. Osel Revenue Growth Rate in Human Microbiome Business (2020-2025)

Figure 60. Symberix Revenue Growth Rate in Human Microbiome Business (2020-2025)

Figure 61. Miomics Revenue Growth Rate in Human Microbiome Business (2020-2025)

Figure 62. Symbiotix Biotherapies Revenue Growth Rate in Human Microbiome Business (2020-2025)

Figure 63. MicroBiome Therapeutics LLC Revenue Growth Rate in Human Microbiome Business (2020-2025)

Figure 64. Bottom-up and Top-down Approaches for This Report

Figure 65. Data Triangulation

Figure 66. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Salt Active Nuclease Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-6W17226

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Parietal Bone Model Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-34V19460

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Genome Editing Enzymes Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-6C20013

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Genome Editing Tool Enzymes Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-37K19803

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions